3750
ADR BioMedical Holdings Inc.
2026/07/21
ADR BioMedical Holdings has formulated a mid-term management plan for 2026-2028, aiming to expand sales from 750 million yen to 4.06 billion yen. The company plans to focus on new businesses and research & development to expand recurring revenue streams.
